FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Underwood Thomas 2. Date of Event Requiring Statement (Month/Day/Year) 09/24/2009 3. Issuer Name and Ticker or Trading Symbol INVERNESS MEDICAL INNOVATIONS INC [IMA] (Last) (First) (Middle) 3200 WINDY HILL ROAD, SUITE B-100 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Information Officer 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) ATLANTA, GA 30339 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	  (1)	08/31/2019	Common Stock	40,000	$ 35.6	D	Â
Employee Stock Option (Right to Buy)	  (2)	06/30/2019	Common Stock	12,000	$ 35.58	D	Â
Employee Stock Option	  (3)	12/13/2018	Common Stock	1,000	$ 18.91	D	Â
Employee Stock Option (Right to Buy)	  (4)	06/30/2018	Common Stock	25,000	$ 33.17	D	Â
Series B Convertible Perpetual Preferred Stock	  (5)	  (6)	Common Stock	22,636 (7)	$ 69.32 (5)	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Underwood Thomas 3200 WINDY HILL ROAD SUITE B-100 ATLANTA, GA 30339	Â	Â	  Chief Information Officer	Â

Signatures

/s/ Jay McNamara, Attorney in Fact		10/02/2009
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This option becomes exercisable in four equal annual installments beginning August 31, 2010.
(2)	This option becomes exercisable in four equal annual installments beginning June 30, 2010.
(3)	This option becomes exercisable in four equal annual installments beginning December 31, 2009.
(4)	This option becomes exercisable in four equal annual installments beginning June 30, 2009.
(5)	Convertible at $69.32, subject to customary antidulition adjustments, if during any calendar quarter the closing price of the common stock exceeds 130% of the Series B conversion price then in effect and in certain other circumstances.
(6)	The Series B preferred stock has no expiration date.
(7)	Each share of Series B preferred stock is convertible, based on a liquidation preference of $400.00 per share into 5.7703 shares of common stock, plus cash in lieu of fractional shares.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.